![](https://img.einnews.com/small/703254/multiple-sclerosis-market-repor.jpeg)
Multiple Sclerosis Market Report 2034: Epidemiology Data, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, Bayer, Novartis, Biogen, Genentech, and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /EINPresswire.com/ -- DelveInsight’s “ …